Skip to content

Search

Showing results for "clinical trials"

Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus

We tested the hypothesis that treatment of CF epithelial cells with ivacaftor (Iva) or ivacaftor/lumacaftor (Iva/Lum) would improve control of rhinovirus infection.

Supporting autistic children guideline - short course

CliniKids has partnered with Autism CRC to deliver an online self-paced short course which explores the Recommendations included within the National Guideline for supporting the learning, participation, and wellbeing of autistic children and their families in Australia.

Service agreements

We are currently working through several clinical audits to ensure that we are meeting our service delivery standards and governance requirements. As part of this, we have audited our Service Agreements to ensure that we have a signed agreement on file for all our clients. This agreement is an NDIS

ABCA3 lung disease in an ex 27 week preterm infant responsive to systemic glucocorticosteroids

This is a case of ABCA3 lung disease that demonstrated improvement after systemic glucocorticosteroid administration

A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand

The objective of this paper is to describe paediatric infectious diseases consultations across Australia and New Zealand.

Pleurodesis outcome in malignant pleural mesothelioma

Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy, patient survival or total time spent in hospital from procedure till death.

PREDICT CF: Assessing the role of lung clearance index in predicting disease progression in children with cystic fibrosis

There is increasing evidence that the assessment of ventilation distribution using the multiple breath washout (MBW) technique is sensitive to changes in disease status of children with cystic fibrosis.

New insight into Rett syndrome severity

A research collaboration between Australia and Israel has identified a genetic variation that influences the severity of symptoms in Rett syndrome.